189 related articles for article (PubMed ID: 30290054)
21. Distribution of Hsp-27 and HER-2/neu in in situ and invasive ductal breast carcinomas.
Storm FK; Gilchrist KW; Warner TF; Mahvi DM
Ann Surg Oncol; 1995 Jan; 2(1):43-8. PubMed ID: 7530588
[TBL] [Abstract][Full Text] [Related]
22. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
23. BNIP3 and NIX mediate Mieap-induced accumulation of lysosomal proteins within mitochondria.
Nakamura Y; Kitamura N; Shinogi D; Yoshida M; Goda O; Murai R; Kamino H; Arakawa H
PLoS One; 2012; 7(1):e30767. PubMed ID: 22292033
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of Intracellular Transcription of Factors HIF-1α and p53 and Their Relation to Estradiol and TNM Parameters of Breast Cancer Tissues in Women with Invasive Ductal Carcinoma in Thi-Qar Province, Iraq.
Ali Khadem Z; Abdul Wadood Al-Shammaree S
Arch Razi Inst; 2022 Aug; 77(4):1341-1348. PubMed ID: 36883155
[TBL] [Abstract][Full Text] [Related]
25. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
[TBL] [Abstract][Full Text] [Related]
26. Expression of periostin in breast cancer cells.
Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Matkowski R; Wojnar A; Rys J; Ugorski M; Dziegiel P
Int J Oncol; 2017 Oct; 51(4):1300-1310. PubMed ID: 28902360
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women.
Kim JH; Shin MH; Kweon SS; Park MH; Yoon JH; Lee JS; Choi C; Fackler MJ; Sukumar S
Gynecol Oncol; 2010 Aug; 118(2):176-81. PubMed ID: 20466412
[TBL] [Abstract][Full Text] [Related]
28. P16 and p53 play distinct roles in different subtypes of breast cancer.
Shan M; Zhang X; Liu X; Qin Y; Liu T; Liu Y; Wang J; Zhong Z; Zhang Y; Geng J; Pang D
PLoS One; 2013; 8(10):e76408. PubMed ID: 24146864
[TBL] [Abstract][Full Text] [Related]
29. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of apoptotic marker p53 as a prognostic factor in breast cancer.
Loskutova KS; Kirillina MP; Lushnikova EL; Nepomnyashchikh LM
Bull Exp Biol Med; 2014 Nov; 158(1):84-7. PubMed ID: 25403404
[TBL] [Abstract][Full Text] [Related]
31. TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
Chitemerere M; Andersen TI; Holm R; Karlsen F; Børresen AL; Nesland JM
Breast Cancer Res Treat; 1996; 41(2):103-9. PubMed ID: 8944328
[TBL] [Abstract][Full Text] [Related]
32. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
[TBL] [Abstract][Full Text] [Related]
33. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.
Conway K; Edmiston SN; May R; Kuan PF; Chu H; Bryant C; Tse CK; Swift-Scanlan T; Geradts J; Troester MA; Millikan RC
Breast Cancer Res; 2014 Oct; 16(5):450. PubMed ID: 25287138
[TBL] [Abstract][Full Text] [Related]
35. Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.
Lisboa BW; Vogtländer S; Gilster T; Riethdorf L; Milde-Langosch K; Löning T
Virchows Arch; 1997 Dec; 431(6):375-81. PubMed ID: 9428925
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer.
Lawson JS; Tran DD; Ford C; Rawlinson WD
Breast Cancer Res Treat; 2004 Sep; 87(1):13-7. PubMed ID: 15377846
[TBL] [Abstract][Full Text] [Related]
38. SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.
Blancato J; Graves A; Rashidi B; Moroni M; Tchobe L; Ozdemirli M; Kallakury B; Makambi KH; Marian C; Mueller SC
PLoS One; 2014; 9(2):e87610. PubMed ID: 24523870
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
40. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
